This is fundamentally undervalued stock based on Microarray growth, huge opportunity The competition has billion + market cap, this deserves to be 50-100 million company based on multiple and growth Ridiculously undervalued.. Total joke to be trading at 0.008, cheapest market cap for what they do and revenues they have -
After AUDIT that comes out in couple of week's as per CEO's comment -This will explode..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.